Pharming Group (PHGUF) News Today $1.14 0.00 (0.00%) As of 08/8/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock PHGUF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Pharming Group (OTCMKTS:PHGUF) Shares Down 0.9% - What's Next?August 5, 2025 | marketbeat.comPharming Group to participate in August investor conference | PHARM Stock NewsAugust 4, 2025 | gurufocus.comPharming Group reports second quarter and first half 2025 financial results and provides ...July 31, 2025 | gurufocus.comPharming Group to report second quarter and first half 2025 financial results and provide ...July 17, 2025 | gurufocus.comPharming Group (PHGN.DU)June 26, 2025 | sg.finance.yahoo.comPharming Group N.V.: Pharming Group reports on results of the 2025 Annual General Meeting of ShareholdersJune 11, 2025 | finanznachrichten.dePharming Group (OTCMKTS:PHGUF) Hits New 52-Week High - Still a Buy?June 6, 2025 | marketbeat.comPharming Group (PHGUF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth ...May 9, 2025 | uk.finance.yahoo.comPharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)April 25, 2025 | finance.yahoo.comPharming announces positive recommendation from NICE for JoenjaApril 24, 2025 | finance.yahoo.comPharming Group to report first quarter 2025 financial results on May 8April 24, 2025 | finance.yahoo.comPharming Group N.V.: Pharming receives positive recommendation from NICE for Joenja?(leniolisib) as a treatment for APDSApril 23, 2025 | finanznachrichten.dePharming Group (OTCMKTS:PHGUF) Short Interest Down 30.8% in MarchApril 20, 2025 | marketbeat.comPharming Group announces the filing of its 2024 Annual Report and Form 20-FApril 3, 2025 | finance.yahoo.comPharming Group (PHAR) Receives a Buy from H.C. WainwrightMarch 21, 2025 | markets.businessinsider.comPharming price target raised to $39 from $30 at OppenheimerMarch 14, 2025 | markets.businessinsider.comPharming Group (PHGUF) Projected to Post Quarterly Earnings on ThursdayMarch 6, 2025 | marketbeat.comPharming Group N.V.: Pharming Group reports on results of the 2025 Extraordinary General Meeting of ShareholdersMarch 4, 2025 | finanznachrichten.dePharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percentFebruary 20, 2025 | uk.finance.yahoo.comPharming Group (OTCMKTS:PHGUF) Stock Passes Below 50-Day Moving Average - What's Next?February 13, 2025 | marketbeat.comPharming Group to participate in February investor conferenceFebruary 10, 2025 | finance.yahoo.comPharming Group (OTCMKTS:PHGUF) Share Price Passes Above 50-Day Moving Average - Here's WhyJanuary 23, 2025 | marketbeat.comPharming Group (OTCMKTS:PHGUF) Shares Cross Above 50 Day Moving Average - Time to Sell?December 27, 2024 | marketbeat.comPharming Group price target raised to EUR 2.15 from EUR 1.60 at RBC CapitalDecember 20, 2024 | markets.businessinsider.comPharming Group (OTCMKTS:PHGUF) Shares Up 10.6% - Here's WhyDecember 19, 2024 | marketbeat.comPharming Group Strengthens Pipeline with Abliva AcquisitionDecember 16, 2024 | msn.comPharming Group N.V. (PHAR)November 23, 2024 | finance.yahoo.comPharming price target lowered to $30 from $31 at OppenheimerOctober 28, 2024 | markets.businessinsider.comPharming Group’s Strong Q3 and CEO TransitionOctober 24, 2024 | msn.comPharming Group reports third quarter 2024 financial results and provides business updateOctober 24, 2024 | markets.businessinsider.comWhere Pharming Stands With AnalystsOctober 15, 2024 | benzinga.comPharming Group (OTCMKTS:PHGUF) Trading Up 13.5% - Should You Buy?October 14, 2024 | marketbeat.comPharming Group to report third quarter 2024 financial results on October 24October 10, 2024 | markets.businessinsider.comOppenheimer Sticks to Its Buy Rating for Pharming Group (PHAR)September 28, 2024 | markets.businessinsider.comPharming announces marketing authorization in the U.K. for Joenja® (leniolisib)September 26, 2024 | finance.yahoo.comStrong Buy on Pharming Group: Robust Revenue Growth and Strategic Advancements Signal Sustained UpsideAugust 2, 2024 | markets.businessinsider.comPharming Group to report second quarter and first half 2024 financial results on August 1July 19, 2024 | finance.yahoo.comPharming Group (OTCMKTS:PHGUF) Sees Large Increase in Short InterestJune 2, 2024 | marketbeat.comPharming Group reports on results of the 2024 Annual General Meeting of ShareholdersMay 21, 2024 | finance.yahoo.comOrchard to lose out on milestone payments as Pharming Group ends collabMay 8, 2024 | bizjournals.comPharming Group N.V.April 28, 2024 | wsj.comPharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025April 19, 2024 | finance.yahoo.comPharming Group announces the placement of €100 million convertible bonds due 2029April 18, 2024 | finance.yahoo.comOptimistic Buy Rating on Pharming Group Backed by Promising Leniolisib Trials and Strategic Market ExpansionApril 8, 2024 | markets.businessinsider.comPharming Group N.V.: Pharming announces completion of enrollment in pediatric clinical trial of leniolisibApril 8, 2024 | finanznachrichten.dePharming Group announces the 2024 Annual General Meeting of ShareholdersApril 4, 2024 | finance.yahoo.comPharming Group to participate in April investor conferencesApril 3, 2024 | finance.yahoo.comPharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent ResultsMarch 17, 2024 | finance.yahoo.comPharming Group Full Year 2023 Earnings: US$0.015 loss per share (vs US$0.021 profit in FY 2022)March 16, 2024 | finance.yahoo.comPharming Group’s Strong Financial Performance and Growth Potential Merit Buy RatingMarch 14, 2024 | markets.businessinsider.com Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGUF and its competitors with MarketBeat's FREE daily newsletter. Email Address PHGUF Media Mentions By Week PHGUF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHGUF News Sentiment▼0.370.48▲Average Medical News Sentiment PHGUF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHGUF Articles This Week▼10▲PHGUF Articles Average Week Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGUF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HCM News APLS News BVNRY News KYMR News RARE News IMVT News ALVO News MIRM News LGND News XENE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PHGUF) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group NV Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale